Hironic Co (149980.KQ) Stock Price

Hironic Co Price

CLOSED
4,525.00
​
Market closed

Revenue has compounded at 8.4% per year over the past 13 years to 32.09 B KRW. Earnings per share have declined at 0.4% per year over the last 13 years. Hironic Co's net margin stands at 9.8%, down from 31.1% several years earlier. Hironic Co currently offers a dividend yield of about 0.82%. The payout ratio is around 12% of earnings. Analysts set a median price target of 16,320.00 KRW, implying 260.7% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Hironic Co stock price

Access this data via the Eulerpool API

Hironic Co business model & stock analysis

Hironic Co., Ltd. engages in the manufacture and sale of skin care medical equipment. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2013-07-01. The firm mainly manufactures medical equipment for skin and obesity care or treatment. The Company’s products include MIXEL, a skin cure equipment for skin lesions and melasma, as well as improving skin texture and tone; MIPL, a skin treatment equipment for pigmentation, wrinkle, vascular, acne and hair removal; MIDEPI, a hair removal equipment; DOUBLO, which is skin treatment equipment for skin tightening and rejuvenation, non-invasive lifting for face and eyebrow lifting; MICOOL, a treatment equipment of natural fat cell destruction, and New Midas, which is used for body contouring and face lifting.

Frequently asked questions about Hironic Co

Analysts currently set an average price target of 16,320.00 KRW for the Hironic Co stock (median: 16,320.00 KRW), implying +260.7 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Hironic Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Hironic Co to generate revenue of 74.44 B KRW and earnings per share of 2,378.48 KRW.

Converted at the current exchange rate, the Hironic Co share trades at 3.02 EUR (4,525.00 KRW).

The expected revenue of Hironic Co is 74.44 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Hironic Co is 29.90 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Hironic Co is currently 1.90. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Hironic Co stock.

The price-to-sales ratio (P/S) of Hironic Co is currently 0.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Hironic Co stock.

The Eulerpool Quality Score for Hironic Co is 4/10.

The ISIN of Hironic Co is KR7149980005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Hironic Co is 149980.KQ. The ticker symbol is used to trade Hironic Co shares on the stock exchange.

Fair ValueTerminal
4,479.75 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Jul 1, 2013
ISIN
KR7149980005
Cusip
G4R101101
Market capitalization
75.55 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
2.53
P/S
P/Se
0.76
EV/EBIT
17.97
P/B Ratio
1.19
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.88 %
Dividend
Dividend yield
0.00 %
Est. Dividend Yield
0.98 %
Payout Ratio
14.32 %
Dividend growth Ø5Y
74.83 %
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 8, 2026, 5:21 PM

Hironic Co Peer Group

Hironic Co FIGI

149980:KS · BBG004RKPK41149980:KQ · BBG004RLDWD6

All fundamentals and in-depth analysis of Hironic Co

Our stock analysis for Hironic Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hironic Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.